We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Improve Access

Improve Access

Building a more equitable cancer care system and shaping a future where cancer care is less expensive.